CAR-T therapy is seen to be on the verge of a breakthrough, raising hopes for both cancer patients as well as medical tourism. But can it become the first line of treatment?
In November 2023, Aster DM had received corporate approvals to separate its India and Gulf Cooperation Council (GCC) businesses into two distinct and standalone entities
Doctors in India view this move as temporary, citing the high number of doctors produced in the country each year
A key task of the committee is to suggest measures to prevent fraud or misuse of the scheme
Recent research suggests that insulin eye drops can be effective in repairing corneal tissue and treating ocular surface conditions
Max Healthcare accused Touch Healthcare of favouring Blackstone's offer over a prior agreement for Care Hospitals' sale
Another pandemic or global scale disaster is inevitable but the Covid experience will help us deal with it better
Indian vaccines and biotech market, which was valued at $4 billion in FY23, accounting for 15 percent of the innovation market, has quickly grown from $1.2 billion in FY20
The ministry on Monday tied up with the Indian Council of Medical Research (ICMR) to conduct the study, which aims at backing up Ayush treatment with scientific and evidence-based research
Union Minister of Chemical and Fertilisers Mansukh Mandaviya on Saturday inaugurated 40 greenfield facilities to manufacture bulk drugs and medical devices under the PLI scheme
Under the agreement, Biocon Biologics will launch Yesafili no later than July 1, 2025. Health Canada had granted tentative approval for Yesafili in March 2023
The increase in ARPOB comes despite significant bed additions by hospitals in the past two financial years
The Pfizer INDovation initiative, which has supported 34 startups in India till now, is now expanding its reach through this collaboration with NIPER Ahmedabad
He said that programs are also being run by the Health Ministry regarding the elimination of Kala-azar. Apart from this, the rural housing scheme also has an important contribution to this
Covid-19 led to increase in self-testing awareness, particularly about preventive and wellness services
Often misunderstood due to its rarity and complex symptoms, this condition requires comprehensive understanding and awareness to ensure timely diagnosis and effective management
The company revealed the price band for its upcoming initial public offering (IPO), set at Rs 177 to 188 per share
A start-up has recently announced that it will provide curated education, health, and edutainment services targeting specific needs using artificial intelligence. The start-up platform called Ascend, which is backed by the Accolade Group, claims to be the first knowpedia (Knowledge pedia). "We are the world's first knowpedia and, currently, focused on health, education, and edutainment. We are using AI and human intervention to provide targeted, curated services and content for individual requirements, which are not available now. We are trying to tap this space," Accolade Knowledge CEO Monika Lahiri said. "Our app will deliver AI-backed solutions for the common man, by aggregating and creating curated content tailored to an individual and offer skill development for re-employability, she said. It is projected that there will be a lot of job redundancy due to the deployment of AI by corporates and businesses, she said. Another Silicon Valley start-up has tied up with Accolade to .
Siddharth Mittal outlines the growth strategies and challenges ahead
Patients to benefit from the move especially in rural areas